MedPath

Prospective and retrospective analysis of amyloidosis patients : Early diagnosis and prognosis factor of amyloidosis

Not Applicable
Recruiting
Conditions
Diseases of the blood and blood -forming organs and certain disorders involving the immune mechanism
Registration Number
KCT0000864
Lead Sponsor
Korea Centers for Disease Control and Prevention
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Inclusion criteria
1) Patients were histologically verified amyloidosis deposition at least one or more organ
Or Patients were reasonable to be diagnosed a cardiac amyloidosis on echocardiography or heart magnetic resonance imaging increasing with immunoglobulin light chain in serum or urine.
- Echocardiography results: mean left ventricular wall thickness >12mm and patients who have no other cardiovascular disease such as valve disease or hypertension
- Heart magnetic resonance imaging results:
Gadolinium delayed enhancement in a wide range of endocardium
2) Patients who were aged 20 years or older
3) Patients who were obtained consent form to participate the research
4) Patients who were written consent form to genetic and biochemical test for research purpose using bone marrow, peripheral blood and tissue obtained for diagnostic purpose

Exclusion Criteria

Exclusion criteria
Patients who do not agree with this study and biochemical and genetic examination

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
motality at anytime
Secondary Outcome Measures
NameTimeMethod
treatment response
© Copyright 2025. All Rights Reserved by MedPath